Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul H Edelstein

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2023
The human proton pump inhibitors inhibit <i>Mycobacterium tuberculosis</i> rifampicin efflux and macrophage-induced rifampicin toleranceM Alexandra Lake, Kristin N Adams, Feilin Nie, et al.
Elife|January 8, 2021
A Bayesian analysis of the association between <i>Leukotriene A4 Hydrolase</i> genotype and survival in tuberculous meningitisLaura Whitworth, Jacob Coxon, Arjan van Laarhoven, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2023
Gaucher disease protects against tuberculosisJingwen Fan, Victoria L Hale, Lindsey T Lelieveld, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2021
Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasoneLaura J Whitworth, Rajan Troll, Antonio J Pagán, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009James R Johnson, Carl Urban, Scott J Weissman, et al.
Clinical Pharmacology and Therapeutics|November 20, 2023
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in TuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Emerging Infectious Diseases|September 6, 2011
Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USAKeith E Simmon, Barbara A Brown-Elliott, Perry G Ridge, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2023
The human proton pump inhibitors inhibit <i>Mycobacterium tuberculosis</i> rifampicin efflux and macrophage-induced rifampicin toleranceM Alexandra Lake, Kristin N Adams, Feilin Nie, et al.
Elife|January 8, 2021
A Bayesian analysis of the association between <i>Leukotriene A4 Hydrolase</i> genotype and survival in tuberculous meningitisLaura Whitworth, Jacob Coxon, Arjan van Laarhoven, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2023
Gaucher disease protects against tuberculosisJingwen Fan, Victoria L Hale, Lindsey T Lelieveld, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2021
Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasoneLaura J Whitworth, Rajan Troll, Antonio J Pagán, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009James R Johnson, Carl Urban, Scott J Weissman, et al.
Clinical Pharmacology and Therapeutics|November 20, 2023
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in TuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Emerging Infectious Diseases|September 6, 2011
Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USAKeith E Simmon, Barbara A Brown-Elliott, Perry G Ridge, et al.
Pageof 8